Conmed (CNMD) Other Non-Current Liabilities (2010 - 2026)

Conmed has reported Other Non-Current Liabilities for 17 years, with the latest figure at $63.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 16.53% year-over-year to $63.0 million; the trailing twelve-month figure through Mar 2026 stood at $63.0 million (down 16.53% YoY), and the FY2025 full-year result was $63.9 million, down 26.01% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $63.0 million, down from $63.9 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $218.1 million in Q3 2022, with the low at $41.8 million in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $113.4 million across 5 years, with a median of $107.3 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 373.8% — and 2024, when it plunged 41.41%.
• Conmed's Other Non-Current Liabilities stood at $203.7 million in 2022, then tumbled by 40.58% to $121.0 million in 2023, then declined by 28.7% to $86.3 million in 2024, then slipped by 26.01% to $63.9 million in 2025, then slipped by 1.3% to $63.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $63.0 million (Q1 2026), $63.9 million (Q4 2025), and $71.7 million (Q3 2025), per Business Quant data.